NASDAQ:TPST

Tempest Therapeutics Stock Forecast

etoro logo Buy TPST
*Your capital is at risk
$1.27
+0 (+0%)
At Close: Jun 09, 2026
AI Analysis AI Analysis of TPST AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TPST to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Tempest Therapeutics Inc. stock price ended at $1.27 on Tuesday, after losing 0%
(Updated on Jun 09, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 15, 2026 Loss -30.60%

No changes to the price of Tempest Therapeutics Inc. stock on the last trading day (Tuesday, 9th Jun 2026). During the last trading day the stock fluctuated 4.03% from a day low at $1.24 to a day high of $1.29. The price has fallen in 6 of the last 10 days and is down by -28.25% for this period.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.24 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.86% during the next 3 months and, with a 90% probability hold a price between $0.97 and $1.52 at the end of this 3-month period.

TPST Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Tempest Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.31 and $1.75. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Tempest Therapeutics Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0500 between high and low, or 4.03%. For the last week the stock has had daily average volatility of 4.83%.

Tempest Therapeutics Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TPST) For The Upcoming Trading Day Of Wednesday 10th

For the upcoming trading day on Wednesday, 10th we expect Tempest Therapeutics Inc. to open at $1.27, and during the day (based on 14 day Average True Range), to move between $1.21 and $1.33, which gives a possible trading interval of +/-$0.116 (+/-9.54%) up or down from last closing price. If Tempest Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 9.54% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.31, some $0.0400 (3.15%) from the current price of $1.27, our system finds the risk reward not very attractive.

Is Tempest Therapeutics Inc. stock A Buy?

Tempest Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.656 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 10, 2026 - $1.27 ( 0.262%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TPST Performance

Trading levels for TPST

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.32 3.67%
R2 1.30 2.17%
R1 1.29 1.24%
Price 1.27
S1 1.25 -1.77%
S2 1.24 -2.70%
S3 1.22 -4.20%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.56 22.83%
R2 1.53 20.47%
R1 1.31 3.15%
Price 1.27
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Tempest Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Tempest Therapeutics Inc. is TPST and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tempest Therapeutics Inc. Stock?
Tempest Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Tempest Therapeutics Inc. Stock?
Tempest Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tempest Therapeutics Inc. Stock.

What's the current price of Tempest Therapeutics Inc. Stock?
As of the end of day on the Jun 09, 2026, the price of an Tempest Therapeutics Inc. (TPST) share was $1.27.

What is the 52-week high and low for Tempest Therapeutics Inc. Stock?
The 52-week high for Tempest Therapeutics Inc. Stock is $12.23 and the 52-week low is $1.23.

What is the market capitalization of Tempest Therapeutics Inc. Stock?
As of the Jun 09, 2026, the market capitalization of Tempest Therapeutics Inc. is 5.64M.

When is the next earnings date for Tempest Therapeutics Inc.?
The upcoming earnings date for Tempest Therapeutics Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT TEMPEST THERAPEUTICS INC.
Tempest Therapeutics
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops T...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
7.38% Jun 05
TPR
$140.47
3.67% Jun 04
N
NVRI
$19.53
8.19% May 20
SAP
$172.39
3.79% May 05
GLBE
$31.61
2.44% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE